SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 515 filers reported holding SEAGEN INC in Q4 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,261,506 | +6.2% | 48,370 | -3.7% | 0.02% | -11.8% |
| Q2 2023 | $9,660,944 | -12.4% | 50,205 | -7.7% | 0.02% | -19.0% |
| Q1 2023 | $11,022,840 | +78.7% | 54,380 | +13.3% | 0.02% | +75.0% |
| Q4 2022 | $6,167,012 | -19.0% | 47,990 | -13.8% | 0.01% | -29.4% |
| Q3 2022 | $7,616,000 | -9.4% | 55,663 | +17.2% | 0.02% | -10.5% |
| Q2 2022 | $8,408,000 | +52.5% | 47,509 | +21.5% | 0.02% | +72.7% |
| Q1 2022 | $5,515,000 | -12.3% | 39,113 | -3.8% | 0.01% | -8.3% |
| Q4 2021 | $6,285,000 | -23.7% | 40,651 | -16.2% | 0.01% | -29.4% |
| Q3 2021 | $8,237,000 | +14.4% | 48,491 | +6.3% | 0.02% | +6.2% |
| Q2 2021 | $7,203,000 | -0.3% | 45,614 | -12.2% | 0.02% | -5.9% |
| Q1 2021 | $7,225,000 | -27.4% | 51,978 | -8.6% | 0.02% | -37.0% |
| Q4 2020 | $9,957,000 | – | 56,842 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |